access your medical records
Home > Research at Avera > Clinical Trials at Avera > Clinical Trials Search Results
Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
The main objective of the trial is to assess the efficacy and tolerability of Lonca-R in unfit and frail participants with previously untreated DLBCL
3 chemos: bendamustine, rituximab, high dose cytarabine & acalabrutinib & studies how well they work in treating patients w/ newly diagnosed mantle cell lymphoma
This is an expanded access protocol that will be conducted at sites qualified and approved to treat subjects with lisocabtagene maraleucel.
This phase III trial compares immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients with newly diagnosed stage III or IV classic Hodgkin lymphoma.
© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.